What’s in a Number? Breast Cancer Risk Assessment Models and Clinical Applications with Jill E. Stopfer, MS, LGC

• Breast cancer risk assessment models are used to estimate lifetime risk for breast cancer, as well as prior probabilities for carrying a pathogenic germline variant in a cancer susceptibility gene. The number and complexity of these models continues to grow, making it imperative that they be thoughtfully applied. This presentation will provide a practical overview of some of the more commonly used risk assessment models, their clinical utility, as well as limitations through case-based presentations.

  Level of Instruction: Intermediate

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Jill Stopfer, MS, LGC | Presenter

Associate Director, Genetic Counseling Dana-Farber Cancer Institute

Jill Stopfer is a licensed genetic counselor with over 30 years of professional experience, and is among the first genetic counselors in the country to focus exclusively in oncology. She is a founding member of the Cancer Risk Evaluation Program at UPenn in 1994 where she led genetic counseling services for over 20 years. She is a founding member of the Cancer Genetics Special Interest Group of the National Society of Genetic Counselors. Jill is currently the Associate Director of Genetic Counseling at the Dana-Farber Cancer Institute in Boston where she helps lead a group of 30 oncology genetic counselors. She has led initiatives to implement novel genetic counseling protocols to ensure efficient access to high quality services across multiple high-volume disease sites and provide services to multiple community sites.

Amanda Jacquart, MS, LCGC | Moderator

Genomic Science Liaison

Amanda Jacquart joined Ambry Genetics in 2022 as the Oncology Genomic Science Liaison for the Midwest territory. In her current role, she provides ongoing clinical and technical genetic testing education to healthcare providers and peers in the field. She practiced as a genetic counselor in the Clinical Cancer Center at Froedtert & the Medical College of Wisconsin. With her appointment as Adjunct Faculty in the Graduate School at MCW, she maintains a close relationship with their genetic counseling training program by serving as a Primary Masters Thesis Advisor. She currently serves as Vice President of the Wisconsin Genetic Counselors Association (WIGCA). Amanda earned her Masters of Science in Genetic Counseling from the University of Pittsburgh and is certified by the American Board of Genetic Counseling.